Trial of Amitriptyline in Chronic Depression

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1963 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 109, pages 54-55 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: J W, GARRY; T J, LEONARD;

doi: 10.1192/bjp.109.458.54

pmid: 13946648

Trial of Amitriptyline in Chronic Depression

- Summary
- Subjects
- Metrics

Abstract

Amitriptyline hydrochloride (“Tryptizol”) is a new antidepressant with a predominant action on the central nervous system. It is 5-(3-di-methylaminopropylidene) - dibenzo (a,d) (1,4) cycloheptadiene hydrochloride, and is related chemically to imipramine.

Keywords

Bipolar Disorder, Psychotic Disorders, Depression, Amitriptyline, Mental Disorders, Humans, Antidepressive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	19
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%